Ignite Creation Date:
2025-12-24 @ 7:41 PM
Ignite Modification Date:
2026-01-01 @ 6:38 PM
Study NCT ID:
NCT00005903
Status:
COMPLETED
Last Update Posted:
2008-03-04
First Post:
2000-06-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Continuously Infused Recombinant-Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (GDNF) to Treat Progressive Supranuclear Palsy
Sponsor:
National Institute of Neurological Disorders and Stroke (NINDS)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
000145
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None